Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)
Е. Л. Насонов(Association of Rheumatologists of Russia), Б. С. Белов(Unknown), Z. N. Sukmarova, Т. В. Попкова(Association of Rheumatologists of Russia)
Cited by 12
Related Papers
RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES
|Rheumatology Science and Practice|2018|151
GENERAL PRINCIPLES OF TREATMENT FOR MUSCULOSKELETAL PAIN: INTERDISCIPLINARY CONSENSUS
|Rheumatology Science and Practice (Nauchno-prakticheskaya revmatologiya) (IMA Press)|2016|62
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
|Rheumatology Science and Practice|2021|54
COVID-19: the new challenge for rheumatologists
|Modern Rheumatology Journal|2020|30
Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)
|Meditsinskiy sovet = Medical Council|2019|14